Craft

Wondfo

Stock Price

¥25.7

2024-10-29

Market Capitalization

¥11.9 B

2024-10-29

Revenue

¥2.1 B

FY, 2025

Wondfo Summary

Company Summary

Overview
Guangzhou Wondfo Biotech is a biotechnology company that specializes in R&D, production, sales, and service of point-of-care testing products and providing rapid diagnosis and chronic disease management solutions. It offers rapid test kits for COVID-19, drug abuse, tumor, infectious diseases, fertility, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases, inflammation, kidney injury, sex hormones, thyroid function, diabetes, etc. The company also delivers blood gas, optical coagulation, and dry chemistry analyzers.
Type
Public
Status
Active
Founded
1992
HQ
Guangzhou, CN | view all locations
Website
https://en.wondfo.com/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

Key People

  • Ji Hua Wang, Chairman

    • Wen Mei Li, General Manager & Director

      • Xiao Wei He, Director

        • Cui Ling Wu, Chairman of Supervisory Board

          Operating MetricsView all

          Inventory

          51.6M
          2.3%

          FY, 2021

          Products in Progress

          601.3M
          49.4%

          FY, 2021

          Products Sold

          600.1M
          59.8%

          FY, 2021

          LocationsView all

          1 location detected

          • Guangzhou, Guangdong Sheng HQ

            China

            No.8 Lizhishan Road, Science City, Luogang District

          Wondfo Financials

          Summary Financials

          Revenue (Q1, 2026)
          ¥573.5M
          Gross profit (Q1, 2026)
          ¥359.6M
          Net income (Q1, 2026)
          ¥86.1M
          Cash (Q1, 2026)
          ¥371.2M
          EBIT (Q1, 2026)
          ¥112.4M
          Enterprise value
          $12.2B

          Footer menu